Investor & Media Home
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Learn more about our pipeline here.
Recent News
FRONT >> News > View All
View All Press Releases
Events & Presentations
Jun 7, 2023 at 9:00 AM EDT
Mar 30, 2023 at 11:30 AM EDT
Feb 26, 2023 at 5:00 PM EST
FRONT > Events - View All
View All Events
Corporate Presentation
More information is coming soon.
FRONT >> Presentations > View All
View Here Presentations